Eli Lilly Strikes $2.75 Billion Deal With AI Drug Pioneer Insilico Medicine to Fast-Track Global Drug Development
Eli Lilly signs a landmark $2.75 billion deal with AI drug pioneer Insilico Medicine, offering $115 million upfront to fast-track AI-generated drugs across multiple disease areas into global markets.